임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
46건 표시
- 2상모집 예정· Primary Immune Thrombocytopenia (ITP)코르티코스테로이드 치료 실패 소아 원발성 면역혈소판감소증 환자에서 엘트롬보팍에 추가한 이아날루맙 연구
A Study of Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.
리드: 노바티스
- 2상모집 예정· PIK3CA-Related Overgrowth Spectrum (PROS)지속적 투여 및 장기 안전성을 위한 알펠리시브(BYL719) 후속 연구
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
리드: 노바티스
- 해당없음모집 예정· Referral and ConsultationOptimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
협력: 노바티스
- 단계 미표기모집 예정· Hidradenitis SuppurativaA Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients
리드: 노바티스
- 1상모집 예정· Recurrent Diffuse Large B-Cell LymphomaLymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
협력: 노바티스
- 3상모집 예정· Acute Coronary Syndrome (ACS)Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL
리드: 노바티스
- 단계 미표기모집 예정· Complement 3 GlomerulopathyA Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain
리드: 노바티스
- 3상모집 예정· Chronic Pruritus of Unknown OriginA Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
리드: 노바티스
- 단계 미표기모집 예정· Metastatic Prostate CancerPULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
리드: 노바티스
- 단계 미표기모집 예정· Plaque PsoriasisA Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
리드: 노바티스
- 단계 미표기모집 예정· Chronic Spontaneous UrticariaRemibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)
리드: 노바티스
- 1상모집 예정· Large-cell LymphomaCAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
협력: 노바티스
- 2상모집 예정· Multiple Sclerosis (MS) - Relapsing-remittingA Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
협력: 노바티스
- 단계 미표기모집 예정· Prostatic Neoplasms, Castration-ResistantPluvicto Real-world Investigation in Survival in Metastatic CRPC
리드: 노바티스
- 단계 미표기모집 예정· Chronic Myeloid LeukemiaA Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
리드: 노바티스
- 1상모집 예정· Elevated Blood PressureHJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
리드: 노바티스
- 단계 미표기모집 예정· Immune ThrombocytopeniaA Real-world Study of Treatment Patterns and Outcomes in Primary Immune Thrombocytopenia Patients Treated With Eltrombopag
리드: 노바티스
- 단계 미표기모집 예정· Leukemia, Myeloid, Chronic-PhaseA Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
리드: 노바티스
- 2상모집 예정· Localized Cutaneous LeishmaniasisA Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
협력: 노바티스
- 2상모집 예정· Cancer of Unknown PrimaryPhase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary
협력: 노바티스
- 단계 미표기모집 예정· Hidradenitis SuppurativaA Real-world Study of Patients With Hidradenitis Suppurativa and High Cardiovascular Risk or Established Coronary Plaque Treated With Secukinumab
리드: 노바티스
- 2상모집 예정· Chronic Myeloid Leukemia (CML) inASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE)
협력: 노바티스
- 해당없음모집 예정· Coronary Artery DiseaseElectronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial
협력: 노바티스
- 4상모집 예정· Sickle Cell Disease (SCD)Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
협력: 노바티스
- 2상모집 예정· Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML
협력: 노바티스
- 단계 미표기모집 예정· Dyslipidemia, HypercholesterolemiaReal World Adherence of PCSK9 Targeted Therapy
리드: 노바티스
- 단계 미표기모집 예정· Kidney DiseasesClinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study
리드: 노바티스
- 해당없음모집 예정· Acute Coronary SyndromesEARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention
협력: 노바티스
- 해당없음모집 예정· Traumatic Brain InjuryNon-invasive Deep Brain Stimulation to Improve Spatial Navigation Abilities in Individuals Following Traumatic Brain Injury
협력: 노바티스
- 단계 미표기모집 예정· Enthesitis-related Arthritis (ERA)Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.
리드: 노바티스
- 단계 미표기모집 예정· Juvenile Idiopathic ArthritisProspective Observational Study to Evaluate Secukinumab Treatment Effectiveness in Pediatric Patients With Active Juvenile Enthesitis-related or Psoriatic Arthritis
리드: 노바티스
- 1/2상모집 예정· KRAS Mutation-Related TumorsTrametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
협력: 노바티스
- 1/2상모집 예정· Sickle Cell DiseaseCrizanlizumab Improves Tissue Oxygen Supply Demand Matching in Patients With Sickle Cell Anemia
협력: 노바티스
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.